Here are five details:
1. For the first half of 2018, the company’s sales are up 22 percent at $19.77 million.
2. In the second quarter of 2018, Medicrea reported about $10.30 million in sales, up from first quarter 2018 sales of $9.59 million.
3. In June, Medicrea raked in $3.98 million in sales, its best month to date.
4. Medicrea recorded 116 patient-specific UNiD Rod surgeries performed in June. Since the technology launched, 2,500 surgeries have used the patient-specific rods.
5. Sales with international distributors grew 40 percent during the first half of 2018. In France, Medicrea continues its market share gains with a 3 percent growth in sales.
More articles on devices and implants:
Globus Medical expands portfolio with 2 new devices
Industry payments to physicians, hospitals drop 4.7% in 2017: 5 things to know
SeaSpine snags former NuVasive VP as new spinal systems executive: 5 observations
